相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Histone deacetylases as new therapy targets for platinum-resistant epithelial ovarian cancer
Dmitri Pchejetski et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2016)
The roles of ncRNAs and histone-modifiers in regulating breast cancer stem cells
Zhiju Zhao et al.
PROTEIN & CELL (2016)
MicroRNA Regulation of Human Breast Cancer Stem Cells
Yohei Shimono et al.
JOURNAL OF CLINICAL MEDICINE (2016)
Global histone modification profiling reveals the epigenomic dynamics during malignant transformation in a four-stage breast cancer model
Quan-Yi Zhao et al.
CLINICAL EPIGENETICS (2016)
Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features
M. Zuberi et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2015)
Screen identifies bromodomain protein ZMYND8 in chromatin recognition of transcription-associated DNA damage that promotes homologous recombination
Fade Gong et al.
GENES & DEVELOPMENT (2015)
BRCA1-like signature in triple negative breast cancer: Molecular and clinical characterization reveals subgroups with therapeutic potential
Tesa M. Severson et al.
MOLECULAR ONCOLOGY (2015)
Ovarian carcinoma CDK12 mutations misregulate expression of DNA repair genes via deficient formation and function of the Cdk12/CycK complex
Kingsley M. Ekumi et al.
NUCLEIC ACIDS RESEARCH (2015)
Interactions between αv-Integrin and HER2 and Their Role in the Invasive Phenotype of Breast Cancer Cells In Vitro and in Rat Brain
Sangeet Lal et al.
PLOS ONE (2015)
miR-223 Regulates Adipogenic and Osteogenic Differentiation of Mesenchymal Stem Cells Through a C/EBPs/miR-223/FGFR2 Regulatory Feedback Loop
Xiaohui Guan et al.
STEM CELLS (2015)
Potential role of miR-100 in cancer diagnosis, prognosis, and therapy
Chu Qin et al.
TUMOR BIOLOGY (2015)
MicroRNA-9 promotes tumorigenesis and mediates sensitivity to cisplatin in primary epithelial ovarian cancer cells
Hong-Min Zhao et al.
TUMOR BIOLOGY (2015)
The cancer COMPASS: navigating the functions of MLL complexes in cancer
David J. Ford et al.
CANCER GENETICS (2015)
Super Enhancers in Cancers, Complex Disease, and Developmental Disorders
Adrienne R. Niederriter et al.
GENES (2015)
Clinically Relevant microRNAs in Ovarian Cancer
Shu Zhang et al.
MOLECULAR CANCER RESEARCH (2015)
Biallelic Mutations in BRCA1 Cause a New Fanconi Anemia Subtype
Sarah L. Sawyer et al.
CANCER DISCOVERY (2015)
Genetic alterations of histone lysine methyltransferases and their significance in breast cancer
Lanxin Liu et al.
ONCOTARGET (2015)
The role of EVI1 in myeloid malignancies
Carolyn Glass et al.
BLOOD CELLS MOLECULES AND DISEASES (2014)
Nucleosome positioning and histone modifications define relationships between regulatory elements and nearby gene expression in breast epithelial cells
Suhn Kyong Rhie et al.
BMC GENOMICS (2014)
Strategies to overcome trastuzumab resistance in HER2-overexpressing breast cancers: focus on new data from clinical trials
Pernelle Lavaud et al.
BMC MEDICINE (2014)
Control of Cell Identity Genes Occurs in Insulated Neighborhoods in Mammalian Chromosomes
Jill M. Dowen et al.
CELL (2014)
Whole genome DNA methylation signature of HER2-positive breast cancer
Breezy M. Lindqvist et al.
EPIGENETICS (2014)
DNA methylation profiles in ovarian cancer: Implication in diagnosis and therapy (Review)
Ourania Koukoura et al.
MOLECULAR MEDICINE REPORTS (2014)
Sleeping Giants: Emerging Roles for the Fat Cadherins in Health and Disease
Elham Sadeqzadeh et al.
MEDICINAL RESEARCH REVIEWS (2014)
Inhibition of HDAC1 and DNMT1 Modulate RGS10 Expression and Decrease Ovarian Cancer Chemoresistance
Ercan Cacan et al.
PLOS ONE (2014)
Aberrant DNA methylation of integrin α4 in human breast cancer
Sung-Im Do et al.
TUMOR BIOLOGY (2014)
Do epigenetic drug treatments hold the key to killing cancer progenitor cells?
Shannon Byler et al.
EPIGENOMICS (2014)
Enhancer alterations in cancer: a source for a cell identity crisis
Ken J. Kron et al.
GENOME MEDICINE (2014)
BRCA 1/2-mutation related and sporadic breast and ovarian cancers: more alike than different
Melissa Burgess et al.
FRONTIERS IN ONCOLOGY (2014)
Histones and their modifications in ovarian cancer-drivers of disease and therapeutic targets
Deborah J. Marsh et al.
FRONTIERS IN ONCOLOGY (2014)
MicroRNA-Antagonism Regulates Breast Cancer Stemness and Metastasis via TET-Family-Dependent Chromatin Remodeling
Su Jung Song et al.
CELL (2013)
The Oncogenic MicroRNA miR-22 Targets the TET2 Tumor Suppressor to Promote Hematopoietic Stem Cell Self-Renewal and Transformation
Su Jung Song et al.
CELL STEM CELL (2013)
Loss of FMR2 further emphasizes the link between deregulation of immediate early response genes FOS and JUN and intellectual disability
Mireille Melko et al.
HUMAN MOLECULAR GENETICS (2013)
Cancer Development, Progression, and Therapy: An Epigenetic Overview
Sibaji Sarkar et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Demethylation and re-expression of epigenetically silenced tumor suppressor genes: sensitization of cancer cells by combination therapy
Sibaji Sarkar et al.
EPIGENOMICS (2013)
A critical review of cost-effectiveness analyses of vaccinating males against human papillomavirus
Yiling Jiang et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Gene Expression Analysis of the Embryonic Subplate
Franziska M. Oeschger et al.
CEREBRAL CORTEX (2012)
Widespread plasticity in CTCF occupancy linked to DNA methylation
Hao Wang et al.
GENOME RESEARCH (2012)
MicroRNA 34c Gene Down-regulation via DNA Methylation Promotes Self-renewal and Epithelial-Mesenchymal Transition in Breast Tumor-initiating Cells
Fengyan Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The landscape of cancer genes and mutational processes in breast cancer
Philip J. Stephens et al.
NATURE (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
Christina Curtis et al.
NATURE (2012)
Epigenetic Silencing Mediated through Activated PI3K/AKT Signaling in Breast Cancer
Tao Zuo et al.
CANCER RESEARCH (2011)
Decreased microRNA-214 levels in breast cancer cells coincides with increased cell proliferation, invasion and accumulation of the Polycomb Ezh2 methyltransferase
Assia Derfoul et al.
CARCINOGENESIS (2011)
Activity of Sorafenib in Recurrent Ovarian Cancer and Primary Peritoneal Carcinomatosis: A Gynecologic Oncology Group Trial
Daniela Matei et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
T-Oligos Inhibit Growth and Induce Apoptosis in Human Ovarian Cancer Cells
Sibaji Sarkar et al.
OLIGONUCLEOTIDES (2011)
Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non-Small Cell Lung Cancer
Rosalyn A. Juergens et al.
CANCER DISCOVERY (2011)
Quantitative copy number analysis by Multiplex Ligation-dependent Probe Amplification (MLPA) of BRCA1-associated breast cancer regions identifies BRCAness
Esther H. Lips et al.
BREAST CANCER RESEARCH (2011)
Epigenetic therapies for chemoresensitization of epithelial ovarian cancer
Daniela E. Matei et al.
GYNECOLOGIC ONCOLOGY (2010)
A Link between mir-100 and FRAP1/mTOR in Clear Cell Ovarian Cancer
Ankur K. Nagaraja et al.
MOLECULAR ENDOCRINOLOGY (2010)
TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
Magali Olivier et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
MicroRNAs and their target gene networks in breast cancer
Elizabeth O'Day et al.
BREAST CANCER RESEARCH (2010)
Global Histone Modifications in Breast Cancer Correlate with Tumor Phenotypes, Prognostic Factors, and Patient Outcome
Somaia E. Elsheikh et al.
CANCER RESEARCH (2009)
BRCA Germline Mutations in Jewish Patients With Pancreatic Adenocarcinoma
Cristina R. Ferrone et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
GATA3 inhibits breast cancer growth and pulmonary breast cancer metastasis
A. B. Dydensborg et al.
ONCOGENE (2009)
The Epidermal Growth Factor Receptor Responsive miR-125a Represses Mesenchymal Morphology in Ovarian Cancer Cells
Karen D. Cowden Dahl et al.
NEOPLASIA (2009)
miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer
Antonis Giannakakis et al.
CANCER BIOLOGY & THERAPY (2008)
MicroRNA expression profiling in human ovarian cancer:: miR-214 induces cell survival and cisplatin resistance by targeting PTEN
Hua Yang et al.
CANCER RESEARCH (2008)
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
Sun-Mi Park et al.
GENES & DEVELOPMENT (2008)
DNA hypermethylation, Her-2/neu overexpression and p53 mutations in ovarian carcinoma
Qinghua Feng et al.
GYNECOLOGIC ONCOLOGY (2008)
Potential role of miR-9 and miR-223 in recurrent ovarian cancer
Alexandros Laios et al.
MOLECULAR CANCER (2008)
Combination therapy of established cancer using a histone deacetylase inhibitor and a TRAIL receptor agonist
Ailsa J. Frew et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Epigenetic mapping and functional analysis in a breast cancer metastasis model using whole-genome promoter tiling microarrays
David I. Rodenhiser et al.
BREAST CANCER RESEARCH (2008)
The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-α (ERα) and represses ERα messenger RNA and protein expression in breast cancer cell lines
Brian D. Adams et al.
MOLECULAR ENDOCRINOLOGY (2007)
Congenital hypothyroid female Pax8-deficient mice are infertile despite thyroid hormone replacement therapy
Jens Mittag et al.
ENDOCRINOLOGY (2007)
DNA methylation of tumor suppressor genes in clinical remission predicts the relapse risk in acute myeloid leukemia
Shuchi Agrawal et al.
CANCER RESEARCH (2007)
TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer
Anita Langerod et al.
BREAST CANCER RESEARCH (2007)
The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis
Gong Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation
Amy Finch et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Epigenetics as a mechanism driving polygenic clinical drug resistance
RM Glasspool et al.
BRITISH JOURNAL OF CANCER (2006)
Breast cancer DNA methylation profiles in cancer cells and tumor stroma: Association with HER-2/neu status in primary breast cancer
H Fiegl et al.
CANCER RESEARCH (2006)
MicroRNA gene expression deregulation in human breast cancer
MV Iorio et al.
CANCER RESEARCH (2005)
Demethylation of the MCJ gene in stage III/IV epithelial ovarian cancer and response to chemotherapy
G Strathdee et al.
GYNECOLOGIC ONCOLOGY (2005)
Tamoxifen-resistant breast cancers show less frequent methylation of the estrogen receptor β but not the estrogen receptor αgene
HG Chang et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2005)
The role of Tbx2 and Tbx3 in mammary development and tumorigenesis
M Rowley et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2004)
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
GA Calin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
TP53 mutations in early-stage ovarian carcinoma, relation to long-term survival
Y Wang et al.
BRITISH JOURNAL OF CANCER (2004)
The acquisition of hMLH1 methylation in plasma DNA after chemotherapy predicts poor survival for ovarian cancer patients
G Gifford et al.
CLINICAL CANCER RESEARCH (2004)
Effect of the codon 7 2 polymorphism (c.215 > C, p.Arg7 2Pro) in combination with somatic sequence variants in the TP53 gene on survival in patients with advanced ovarian carcinoma
Y Wang et al.
HUMAN MUTATION (2004)
Reactivation of the silenced and imprinted alleles of ARHI is associated with increased histone H3 acetylation and decreased histone H3 lysine 9 methylation
S Fujii et al.
HUMAN MOLECULAR GENETICS (2003)
Biallelic inactivation of BRCA2 in Fanconi anemia
NG Howlett et al.
SCIENCE (2002)
Differential mRNA expression of the human DNA methyltransferases (DNMTs) 1,3a and 3b during the G0/G1 to S phase transition in normal and tumor cells
KD Robertson et al.
NUCLEIC ACIDS RESEARCH (2000)
分享论文
